Recombinant‐follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment
Recombinant‐follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment
复制标题
重组促卵泡激素在卵巢过度刺激辅助生殖技术治疗中比尿人更年期促性腺激素更有效
DOI：
10.1111/j.1447-0578.2007.00161.x
复制
发表时间：
2007
影响因子：
3.4
通讯作者：
H. Saito
中科院分区：
文献类型：
--
作者：
K. Nakagawa;S. Ohgi;Rieko Kojima;Kana Sugawara;T. Horikawa;Megumu Ito;M. Irahara;H. Saito
目的： 本研究的目的是建立促性腺激素释放激素类似物 (GnRH-a) 卵巢刺激的标准方案，使用重组促卵泡激素 (rec-FSH) 制剂进行辅助生殖技术 (ART) 治疗。
Aim: The aim of the present study was to establish a standard protocol for ovarian stimulation with gonadotropin‐releasing hormone analog (GnRH‐a) long protocol using recombinant‐follicle stimulating hormone (rec‐FSH) preparations for assisted reproductive technology (ART) treatment.